NYSEMKT: FOXOFoxo Technologies Inc Stock
$0.50-0.01 (-1.96%)
Updated Dec 9, 2024
FOXO Price
$0.50
Fair Value Price
N/A
Market Cap
$8.74M
52 Week Low
$0.13
52 Week High
$1.30
P/E
12.5x
P/B
-0.5x
P/S
1.93x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.34M
Earnings
-$9.47M
Gross Margin
52.7%
Operating Margin
-557.27%
Profit Margin
-784.9%
Debt to Equity
-3.44
Operating Cash Flow
-$1M
Beta
1.77
Next Earnings
Jan 17, 2025
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FOXO's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Value
A
Growth
C
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
FOXO
Ranked#34 of 52
Ranked#34 of 52
Be the first to know about important FOXO news, forecast changes, insider trades & much more!
FOXO News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FOXO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FOXO was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FOXO is good value based on its earnings relative to its share price (12.5x), compared to the US market average (29.44x)
P/E vs Market Valuation
FOXO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more FOXO due diligence checks available for Premium users.
Valuation
FOXO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
12.5x
Industry
24.56x
Market
29.44x
FOXO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FOXO is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
FOXO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.5x
Industry
3.86x
FOXO's financial health
Profit margin
Revenue
$1.2M
Net Income
-$1.9M
Profit Margin
-170.1%
FOXO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FOXO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$42.7M
Liabilities
$60.2M
Debt to equity
-3.44
FOXO's short-term liabilities ($34.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FOXO's long-term liabilities ($25.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FOXO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FOXO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.5M
Investing
$2.4M
Financing
-$848.0k
FOXO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FOXO vs Health Information Service Stocks
Foxo Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.